Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

BLEOMYCIN FOR INJECTION USP

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of BLEOMYCIN FOR INJECTION USP in Canada?

A shortage of BLEOMYCIN FOR INJECTION USP 15UNIT is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 1, 2026), but it has not started yet.

Why is BLEOMYCIN FOR INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will BLEOMYCIN FOR INJECTION USP be available again?

The manufacturer's estimated resolution date is December 31, 2028. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file1 product
Expected resolution~26 months remaining (estimate)
Affected strength15UNIT
Report last updated2026-10-01
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

BLEOMYCIN FOR INJECTION

FRESENIUS KABI CANADA LTD

15UNIT · DIN 02265982

Same strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02131692

Strength

15UNIT

Dosage Form

POWDER FOR SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR INTRACAVITARY INTRA-ARTERIAL

Active Ingredient

BLEOMYCIN

See all BLEOMYCIN products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History